Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,305 | 21,474 | 2,954 | 8,289 | 8,028 |
| Receivables | 4,493 | 2,550 | 3,702 | 2,651 | 3,899 |
| Other current assets | 512 | 5,682 | 137 | 1,544 | 2,404 |
| TOTAL | $37,310 | $29,706 | $6,793 | $12,484 | $14,331 |
| Non-Current Assets | |||||
| PPE Net | 1 | N/A | N/A | 157 | N/A |
| Other Non-Current Assets | 62 | 0 | 0 | 0 | 0 |
| TOTAL | $63 | $N/A | $N/A | $157 | $N/A |
| Total Assets | $37,373 | $29,807 | $6,868 | $12,607 | $14,461 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,048 | 1,668 | 1,336 | 3,030 | 2,366 |
| Other current liabilities | 617 | 567 | 382 | 414 | 544 |
| TOTAL | $1,698 | $2,289 | $1,770 | $3,524 | $2,928 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 43 | 0 | 28 | 0 | 50 |
| TOTAL | $43 | $N/A | $28 | $N/A | $50 |
| Total Liabilities | $1,741 | $2,346 | $1,798 | $3,558 | $2,977 |
| Shareholders' Equity | |||||
| Common Shares | 185,498 | 170,286 | 145,556 | 146,344 | 140,079 |
| Retained earnings | -153,894 | -146,286 | -143,920 | -140,447 | -131,383 |
| Other shareholders' equity | 4,028 | 3,460 | 3,435 | 3,152 | 2,787 |
| TOTAL | $35,632 | $27,460 | $5,070 | $9,049 | $11,483 |
| Total Liabilities And Equity | $37,373 | $29,806 | $6,868 | $12,607 | $14,460 |